Jinghua Pharmaceutical (002349.SZ) released semi-annual results, with net profit of 136 million yuan to mother, an increase of 4.2% over the previous year

According to Zhitong Finance App News, Jinghua Pharmaceutical (002349.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 755 million yuan, up 3.19% year on year; net profit attributable to shareholders of listed companies was 136 million yuan, up 4.2% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 132 million yuan, up 3.92% year on year; basic earnings per share were 0.1672 yuan.